Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

FENC

Fennec Pharmaceuticals Inc

Jun 09 • 04:00PM ET

8.77

-0.13 -1.46 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: OBIO RNAC SLGL HRTX ARCT BCYC FATE FHTX VYGR CDXS

| Held by: IWM VTI IWN VTWO IWC IWO OMFS RSSL VTWV VTWG

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.30	Insider Own	14.53%	Shs Outstand	34.54M	Perf Week	-12.12%
Market Cap	304.64M	Forward P/E	8.67	EPS next Y	1.01	Insider Trans	-17.50%	Shs Float	29.69M	Perf Month	26.55%
Enterprise Value	264.46M	PEG	-	EPS next Q	0.02	Inst Own	57.64%	Short Float	1.68%	Perf Quarter	11.15%
Income	-8.73M	P/S	5.97	EPS this Y	175.10%	Inst Trans	0.04%	Short Ratio	1.93	Perf Half Y	16.16%
Sales	51.00M	P/B	8.04	EPS next Y	284.78%	ROA	-14.77%	Short Interest	0.50M	Perf YTD	13.90%
Book/sh	1.09	P/C	7.58	EPS next 5Y	-	ROE	-54.93%	52W High	10.45 -16.08%	Perf Year	6.30%
Cash/sh	1.16	P/FCF	-	EPS past 3/5Y	27.71% 14.90%	ROIC	-23.18%	52W Low	5.65 55.22%	Perf 3Y	1.62%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	207.52% 204.69%	Gross Margin	92.23%	Volatility	6.67% 7.29%	Perf 5Y	24.40%
Dividend TTM	-	EV/Sales	5.19	EPS Y/Y TTM	42.43%	Oper. Margin	-11.87%	ATR (14)	0.56	Perf 10Y	250.80%
Dividend Ex-Date	-	Quick Ratio	6.78	Sales Y/Y TTM	64.98%	Profit Margin	-17.12%	RSI (14)	50.31	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.98	EPS Q/Q	113.27%	SMA20	-5.70%	Beta	1.11	Target Price	15.57
Payout	-	Debt/Eq	0.00	Sales Q/Q	72.64%	SMA50	14.87%	Rel Volume	0.57	Prev Close	8.90
Employees	35	LT Debt/Eq	0.00	Earnings	May 14 BMO	SMA200	9.25%	Avg Volume	257.58K	Price	8.77
IPO	Oct 22, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	122.78% 8.64%	Trades		Volume	149,275	Change	-1.46%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)